Volume 8, Issue 2, 2024
Risk factors for prevalent and incident hypertension in rheumatoid arthritis: data from the Canadian Early Arthritis Cohort
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae066, https://doi.org/10.1093/rap/rkae066
Editorial
Right clinician, right place, right time: the role of the first contact practitioner from a rheumatology perspective
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae032, https://doi.org/10.1093/rap/rkae032
Leflunomide as a therapeutic alternative to methotrexate as a glucocorticoid-sparing agent in polymyalgia rheumatica
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae047, https://doi.org/10.1093/rap/rkae047
Systematic Review and Meta-Analysis
Characteristics of long COVID in patients with autoimmune rheumatic diseases: a systematic review and meta-analysis
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae027, https://doi.org/10.1093/rap/rkae027
Lifestyle interventions in the management of systemic sclerosis: a systematic review of the literature
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae037, https://doi.org/10.1093/rap/rkae037
A systematic review on the effects of non-pharmacological interventions for fatigue among people with upper and/or lower limb osteoarthritis
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae050, https://doi.org/10.1093/rap/rkae050
Disease-specific definitions of new bone formation on spine radiographs: a systematic literature review
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae061, https://doi.org/10.1093/rap/rkae061
Reviews
Current and future advances in practice: IgG4-related disease
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae020, https://doi.org/10.1093/rap/rkae020
Current and future advances in practice: tendinopathies of the hip
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae022, https://doi.org/10.1093/rap/rkae022
Current and future advances in practice: aromatase inhibitor–induced arthralgia
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae024, https://doi.org/10.1093/rap/rkae024
Original Articles
‘What is my risk really?’: a qualitative exploration of preventive interventions among individuals at risk of rheumatoid arthritis
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae023, https://doi.org/10.1093/rap/rkae023
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae028, https://doi.org/10.1093/rap/rkae028
Effectiveness of methotrexate and leflunomide as corticoid-sparing drugs in patients with polymyalgia rheumatica
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae033, https://doi.org/10.1093/rap/rkae033
Coalition for Health and Gender Equity (CHANGE)—a protocol for a global cross-sectional survey of health and gender equity in rheumatology
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae021, https://doi.org/10.1093/rap/rkae021
Gastric dysrhythmias in patients with early systemic sclerosis: a cross-sectional study
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae041, https://doi.org/10.1093/rap/rkae041
Work participation and the COVID-19 pandemic: an observational study in people with inflammatory rheumatic diseases and population controls
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae026, https://doi.org/10.1093/rap/rkae026
Experiences of systemic sclerosis patients with home monitoring of their pulmonary function: a qualitative study
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae036, https://doi.org/10.1093/rap/rkae036
Overcoming provider barriers to therapeutic drug monitoring of tumour necrosis factor inhibitors for rheumatoid arthritis: a qualitative analysis
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae030, https://doi.org/10.1093/rap/rkae030
Assessment of central nervous system vasculitis in children based on high-resolution vascular wall imaging
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae038, https://doi.org/10.1093/rap/rkae038
Impact of a resilience-building energy management intervention for people with systemic sclerosis: a mixed methods study
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae040, https://doi.org/10.1093/rap/rkae040
A content analysis of medication adherence material in patient educational resources about gout
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae042, https://doi.org/10.1093/rap/rkae042
Testing a candidate composite serum protein marker of skin severity in systemic sclerosis
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae039, https://doi.org/10.1093/rap/rkae039
BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studies
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae058, https://doi.org/10.1093/rap/rkae058
Trust performance in managing inflammatory arthritis over time in England and Wales: a latent class analysis approach
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae053, https://doi.org/10.1093/rap/rkae053
Physician estimate of inflammation vs global assessment in explaining variations in swollen joint counts in rheumatoid arthritis patients
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae057, https://doi.org/10.1093/rap/rkae057
Cerebrovascular disease in patients with antiphospholipid antibody syndrome: a transcranial Doppler and magnetic resonance imaging study
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae060, https://doi.org/10.1093/rap/rkae060
Comparing clinical profiles in spondyloarthritis with Crohn’s disease or ulcerative colitis: insights from the ASAS-PerSpA study
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae064, https://doi.org/10.1093/rap/rkae064
Determinants of tofacitinib discontinuation in adult patients with rheumatoid arthritis during long-term extension studies up to 9.5 years
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae063, https://doi.org/10.1093/rap/rkae063
Exercise as an anti-inflammatory Therapy in Axial Spondyloarthritis Therapeutic Intervention (EXTASI) study: a randomized controlled trial
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae062, https://doi.org/10.1093/rap/rkae062
Targeting enhanced cell death represents a potential therapeutic strategy for VEXAS syndrome
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae065, https://doi.org/10.1093/rap/rkae065
Concise Report
Effectiveness and safety of eltrombopag in connective tissue disease patients with refractory immune thrombocytopenia: a retrospective study
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae029, https://doi.org/10.1093/rap/rkae029
Beyond sicca: high prevalence and predictors of baseline and worsening systemic involvement in patients with Sjögren’s disease
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae035, https://doi.org/10.1093/rap/rkae035
Health literacy and gout characteristics in a primary care cohort
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae034, https://doi.org/10.1093/rap/rkae034
Mortality, bone density and grip strength: lessons from the past and hope for the future?
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae046, https://doi.org/10.1093/rap/rkae046
RPA3-UMAD1 rs12702634 and rheumatoid arthritis–associated interstitial lung disease in European ancestry
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae059, https://doi.org/10.1093/rap/rkae059
Clinical Vignette
Delayed diagnosis of vertebral fracture in long-standing ankylosing spondylitis
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae025, https://doi.org/10.1093/rap/rkae025
Chronic non-bacterial osteomyelitis associated with psoriasis
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae052, https://doi.org/10.1093/rap/rkae052
Power Doppler ultrasonography findings of eosinophilic fasciitis
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae067, https://doi.org/10.1093/rap/rkae067
Clinical science
Clinical phenotyping in patients with anti-synthetase antibodies using cluster analysis
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae049, https://doi.org/10.1093/rap/rkae049
Guideline
The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scope
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae056, https://doi.org/10.1093/rap/rkae056
Letters to the Editor
Area postrema syndrome secondary to primary Sjogren’s syndrome
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae031, https://doi.org/10.1093/rap/rkae031
Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae044, https://doi.org/10.1093/rap/rkae044
Metabolic bone training in the United Kingdom: is the future of bone health at risk of breaking?
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae043, https://doi.org/10.1093/rap/rkae043
ANCA-associated vasculitis with isolated splenomegaly as the initial organ presentation
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae045, https://doi.org/10.1093/rap/rkae045
A vasculitis mimic during pregnancy: autoimmune progesterone dermatitis
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae048, https://doi.org/10.1093/rap/rkae048
The influence of deprivation in the outcomes of psoriatic arthritis within the UK—utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae051, https://doi.org/10.1093/rap/rkae051
Life after tocilizumab given for giant cell arteritis: a patient survey and argument for re-treatment
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae054, https://doi.org/10.1093/rap/rkae054
Does a history of smoking increase the risk of developing systemic sclerosis? Insights from the Leiden Combined Care in Systemic Sclerosis cohort
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae055, https://doi.org/10.1093/rap/rkae055
